Only Shaymaa Elgaafary et al. [17] reported a case of male breast high-grade B cell lymphoma with MYC and BCL2 rearrangement, and genome-wide chromosomal imbalance mapping revealed a complex pattern of aberrations, including copy-number gains in chromosomes 3q and 18 and focal homozygous loss in 9p21.3, resembling typical changes of lymphomas affecting “immune-privileged” sites. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.